🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Karen Tsai

ORCID: 0000-0003-2977-5849

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus”.

Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus

Frontiers in Endocrinology(2023)10.3389/fendo.2023.1242830

N/A

0.312DataRank · unranked

7 citations

Karen Tsai, Zoe Quandt, Dayna J Isaacs, Alexandra Drakaki, Yan Xing +4 more

The Effect of Apalutamide on Thyroid Function in Prostate Cancer Patients

Journal of the Endocrine Society(2024)10.1210/jendso/bvae105

N/A

0.292DataRank · unranked

6 citations

Melissa G. Lechner, Trevor E. Angell, John Shen, Alexandra Drakaki, Gonzalo J. Acosta +3 more

Hypoglycemic episodes predict length of stay in patients with acute burns

Journal of Critical Care(2021)10.1016/j.jcrc.2021.03.005

N/A

0.241DataRank · unranked

4 citations

Sebastian Q Vrouwe, Karen Tsai, Li Ding, Zachary J Collier, Andrea C Grote +5 more

Safety and clinical outcomes of pembrolizumab standard-interval dosing versus extended-interval dosing in patients with breast cancer

The Oncologist(2025)10.1093/oncolo/oyaf371

N/A

0.104DataRank · unranked

1 citations

Austin Kordic, Nora Ruel, Joanne Mortimer, Irene Kang, Heather L. McArthur +3 more

The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function

Thyroid(2024)10.1089/thy.2023.0542

N/A

0DataRank · unranked

17 citations

Huiyan Ma, Tom Z. Liang, Yan Xing, Samuel Chung, Tanya B. Dorff +3 more

Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancer

The Oncologist(2025)10.1093/oncolo/oyaf134

N/A

0DataRank · unranked

2 citations

Esther Peluso, Melissa G. Lechner, Nora Ruel, Joanne Mortimer, Irene Kang +2 more